16 March 2023>: Articles
A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary Aspergillosis
Unusual or unexpected effect of treatment, Adverse events of drug therapy , Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathologyAdebola Oluwabusayo Adetiloye B* , Farhana Alladin E , Rasha Alaameri E , Julio C. Valencia-Manrique E , Olurotimi Badero E , Armeen Poor E
Am J Case Rep 2023; 24:e938359
Figure 5. CT scan of the chest at 9 months of Itraconazole treatment showing resolution of previously extensive airspace disease with decrease in the size of the upper-lobe cavity and fungal ball.